Inhibitory Antibodies
-
F1433 Anti-CD137 & Her2 Antibody (Cinrebafusp alfa)Summary: Anti-CD137 & Her2 Antibody (Cinrebafusp alfa) -
F1434 Anti-ERBB2/HER2/CD340 Antibody (Anbenitamab)Summary: Anti-ERBB2/HER2/CD340 Antibody (Anbenitamab) -
F1435 Anti-HER3 & IGF-1R Antibody (Elgemtumab)Summary: Anti-HER3 & IGF-1R Antibody (Elgemtumab) -
F1436 Anti-ERBB2/HER2/CD340 Antibody (Zanidatamab)Summary: Anti-ERBB2/HER2/CD340 Antibody (Zanidatamab) -
F1437 Anti-HER2 & PD-1 Antibody (Fidasimtamab)Summary: Anti-HER2 & PD-1 Antibody (Fidasimtamab) -
F1438 Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Tisotumab vedotin)Summary: Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Tisotumab vedotin) -
F1439 Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab vedotin)Summary: Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab vedotin) -
F1440 Anti-ENTPD1/CD39 Antibody (TTX-030)Summary: Anti-ENTPD1/CD39 Antibody (TTX-030) -
F1441 Anti-Siglec-3/CD33 Antibody (Gemtuzumab-CLM)Summary: Anti-Siglec-3/CD33 Antibody (Gemtuzumab-CLM) -
F1442 Anti-ANO1/TMEM16A Antibody (Novartis patent anti-TMEM16A )Summary: Anti-ANO1/TMEM16A Antibody (Novartis patent anti-TMEM16A )